International Stem Cell Corp. shares closed at $1.62 a share today after trading in a range of $1.60 – $1.72. This company was mentioned in the QualityStocks FREE Daily Newsletter back on January 28, 2010. At the time, the stock was trading for only $1.16 a share. Anyone buying the stock after reading about it in the QualityStocks Newsletter has made nearly 50% on their investment in just over four weeks.
The core technology of International Stem Cell’s – parthenogenesis – results in the creation of pluripotent human stem cells from unfertilized eggs. This avoids ethical issues associated with the use or destruction of viable human embryos. The company announced today that human stem cell lines created by scientists from its research and development group have demonstrated the ability to maintain the essential properties of immortal stem cells throughout extended laboratory cultivation. This ability is extremely important for the company’s property to have therapeutic value.
International Stem Cell is just the kind of emerging company with exciting growth potential that QualityStocks tries to discover and then expose to the rest of the investment community. The ‘one and only’ QualityStocks Daily collates data and stock selections from hundreds of investment newsletters which specialize in the micro-cap and small-cap markets. The newsletter’s summary format allows readers to view the latest stock picks each and every day in an easy-to-use format. To sign-up for the free newsletter, please visit www.signup.qualitystocks.net.
About QualityStocks:
QualityStocks’ Small Cap Stock Newsletter is a free service that collects data from hundreds of Small-Cap online Investment Newsletters into one free Daily Newsletter Report.
Sign up for “The QualityStocks Daily Newsletter” please visit www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks “Ones to Watch” http://Gotstocks.QualityStocks.net
Please see disclaimer on QualityStocks website: http://disclaimer.qualitystocks.net
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment